An American team focuses its efforts on a new experimental Alzheimer’s vaccine
The Gates Biomanufacturing Facility at the Anschutz Medical Campus of the University of Colorado (United States) has announced the completion of the production process of an experimental recombinant protein against Alzheimer’s disease that will be tested as a vaccine in clinical trials. This vaccine, known as AV-1980R, can be used to … The Gates Biomanufacturing … Read more